Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is 'expensive' on EV/EBITDA.
Target Price
The average target price of OPK is 3.4 and suggests 180% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell